ArticleHemaSphere2024

Long-term immune changes in patients with relapsed/refractory chronic lymphocytic leukemia following treatment with venetoclax plus rituximab.

Arnon P Kater et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.